Evotec is seeking an accomplished and strategic SVP Head of Financial Planning & Analysis (FP&A) to lead the global FP&A function and serve as a critical partner to the CFO and Executive Leadership. This senior role will shape investor-facing communications, deliver compelling financial narratives, and support capital markets engagement. The SVP will oversee global budgeting, forecasting, and long-range planning processes, ensuring alignment with corporate strategy and operational performance. With a focus on value creation, data-driven decision-making, and finance transformation, this leader will guide a high-performing team, optimize financial systems, and coordinate cross-functionally to drive consistent, transparent, and strategic financial insight across the organization. The position can be based at either our Headquarters in Hamburg, Germany or in Abingdon, UK. This is a senior leadership position within our Global FP&A and Controllership organization, reporting to the EVP Global FP&A and Controllership.
Key Responsibilities:
Act as a key strategic partner to the CFO, and EVP Global FP&A and Controllership, on financial presentations, capital markets communication, and investor engagement.
Prepare and manage external presentations and messaging for investors, analysts, and other key stakeholders, including earnings materials, investor days, and board-level briefings.
Develop and deliver compelling financial narratives to support market communications, M&A activity, and long-term positioning of the Group.
Lead the global financial planning and analysis (FP&A) function, ensuring strategic alignment, transparency, and value creation across all regions and business units.
Drive the annual budget, rolling forecast, and long-range planning process, ensuring integration with business strategy and market outlook.
Identify and track key performance indicators (KPIs) to drive business accountability and highlight strategic opportunities or risks.
Lead and develop a high-performing team of six, creating a culture of excellence, collaboration, and strategic insight.
Coordinate cross-functionally with Finance Business Partnering and Global Business Controlling to deliver consistent and aligned financial support globally.
Own and optimize the global financial data model, including internal financial reporting and planning tools for decision-making at all levels.
Champion the Tech Strategy within Finance, driving modernization of reporting systems and data infrastructure in support of finance transformation.
Ideal Qualifications:
University degree in Finance, Accounting, Business, Economics, or a related discipline; MBA or advanced degree preferred.
Extensive experience in financial strategy, investor relations, or market communications, preferably in pharma, life sciences, or management consulting.
Strong background in consulting or corporate strategy, with a proven ability to distill complex financial data into actionable insights and market narratives.
Track record of executive-level business partnering, with excellent communication and presentation skills tailored to internal and external audiences.
Experience managing international finance teams and global planning cycles.
Strong command of financial systems, reporting tools, and data modelling best practices.
Excellent English communication skills (written and verbal); additional languages are a plus.
A truly international mindset, with experience working in multinational and cross-cultural environments.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
